Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NITAZOXANIDE, with a corresponding US DMF Number 33059.
Remarkably, this DMF maintains an Active status since its submission on July 26, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 27, 2019, and payment made on July 22, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II